Provided by Tiger Fintech (Singapore) Pte. Ltd.

OncoCyte Corporation

2.79
-0.0050-0.18%
Volume:788.00
Turnover:2.19K
Market Cap:79.65M
PE:-0.83
High:2.79
Open:2.78
Low:2.78
Close:2.79
Loading ...
Feb 14, 2020

Major Issues Report

Current report, item 5.02
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Major Issues Report

Current report, items 2.01, 3.02, 7.01, and 9.01
Jan 10, 2020

Major Issues Report

Current report, items 1.01, 3.02, 7.01, and 9.01
Jan 06, 2020

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Jan 06, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 27, 2019

Major Issues Report

Current report, items 1.01, 1.02, 2.03, and 9.01
Nov 22, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 14, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Oct 21, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 9.01
Oct 03, 2019

Major Issues Report

Current report, items 1.01, 2.01, 7.01, and 9.01
Sep 13, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Sep 13, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Sep 05, 2019

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Sep 05, 2019

Major Issues Report

[Amend] Current report, item 9.01
Aug 15, 2019

Major Issues Report

Current report, item 5.02
Aug 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]